Mathes Company, Inc. Amgen Inc Transaction History

Mathes Company, Inc.

$283 Million
Q3 2024

A detailed history of Mathes Company, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Mathes Company, Inc. holds 3,205 shares of AMGN stock, worth $943,968. This represents 0.36% of its overall portfolio holdings.

Number of Shares

3,205

Previous 3,330 3.75%

Holding current value

$943,968

Previous $1.04 Million 0.58%

% of portfolio

0.36%

Previous 0.38%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $38,672 - $42,172	-125 Reduced 3.75%	3,205 $1.03 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $78,825 - $95,793	-300 Reduced 8.26%	3,330 $1.04 Million
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $13,443 - $16,228	-50 Reduced 1.36%	3,630 $1.03 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $5,028 - $6,243	-23 Reduced 0.62%	3,680 $989,000
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $2,142 - $2,533	10 Added 0.27%	3,703 $822,000
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $57,257 - $72,752	-250 Reduced 6.34%	3,693 $970,000
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $2,693 - $3,037	-12 Reduced 0.3%	3,943 $889,000
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $49,602 - $55,199	-215 Reduced 5.16%	3,955 $962,000
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $2,983 - $3,414	-15 Reduced 0.36%	4,170 $938,000
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 1.18%	4,185 $890,000
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $46,716 - $51,828	-200 Reduced 4.51%	4,235 $1.03 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $10,429 - $12,154	-47 Reduced 1.05%	4,435 $1.1 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $4,976 - $5,926	-23 Reduced 0.51%	4,482 $1.03 Million
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $11,845 - $15,710	-65 Reduced 1.42%	4,505 $913,000
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $169,113 - $190,627	-935 Reduced 16.98%	4,570 $868,000
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $4,235 - $4,950	-25 Reduced 0.45%	5,505 $938,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $925,113 - $1.06 Million	5,530	5,530 $1.03 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Account

Mathes Company, Inc. Amgen Inc Transaction History